Organogenesis Holdings Inc logo

Organogenesis Holdings Inc

$ 3.22 +0.08 (+2.55%) 08:08 PM EST
P/E:
5.86
P/B:
1.65
Market Cap:
$ 437.56M
Enterprise V:
$ 426.85M
Volume:
608.47K
Avg Vol (2M):
1.24M
Also Trade In:
Volume:
608.47K
Market Cap $:
437.56M
PE Ratio:
5.86
Avg Vol (2-Month):
1.24M
Enterprise Value $:
426.85M
PB Ratio:
1.65
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Name Current Vs Industry Vs History
Cash-To-Debt 0.88
Equity-to-Asset 0.56
Debt-to-Equity 0.5
Debt-to-EBITDA 1.94
Interest Coverage 13.03
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.79
Distress
Grey
Safe
Beneish M-Score -2.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 18.86
9-Day RSI 25.45
14-Day RSI 28.91
6-1 Month Momentum % -46.27
12-1 Month Momentum % -74.84

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.62
Quick Ratio 2.36
Cash Ratio 1.27
Days Inventory 84.96
Days Sales Outstanding 63.56
Days Payable 98.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.1

Financials (Next Earnings Date:2022-11-09 Est.)

ORGO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ORGO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 461.829
EPS (TTM) ($) 0.551
Beta 1.89
Volatility % 46.79
14-Day RSI 28.91
14-Day ATR ($) 0.208919
20-Day SMA ($) 3.495
12-1 Month Momentum % -74.84
52-Week Range ($) 3.08 - 15.26
Shares Outstanding (Mil) 130.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Organogenesis Holdings Inc Filings

Document Form Filing Date
No Filing Data

Organogenesis Holdings Inc Analysis

Share your research

Headlines

See More
No news.